![Ethyl 3-(2-((4-carbamimidoylphenylamino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate hydrochloride](https://img.chemicalbook.in/ProductImageIndia/2024-03/Large/a0dfe5b3-3791-45bf-b8bf-3ed50c10b7ba.png)
![Ethyl 3-(2-((4-carbamimidoylphenylamino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate hydrochloride](https://img.chemicalbook.in/ProductImageIndia/2024-03/Small/a0dfe5b3-3791-45bf-b8bf-3ed50c10b7ba.png)
![Ethyl 3-(2-((4-carbamimidoylphenylamino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate hydrochloride](https://img.chemicalbook.in/ProductImageIndia/2024-03/Small/ed0079c8-951f-40d6-b810-073d726298e3.png)
429658-95-7 98%
Product Details
- Product NameEthyl 3-(2-((4-carbamimidoylphenylamino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate hydrochloride
- CAS No.429658-95-7
- EINECS No.695-000-6
- MFC27H29N7O3
- MW499.57
- AppearancePowderWhite to off-white
- density 1.31
- Boiling point 759.5±70.0 °C(Predicted)
- storage temp. Store at -20°C
Company Profile Introduction
Lofty Laboratories was founded in 2005 with a focus of creating impact in pharmaceutics value chain. Today we are a leading pharmaceutical bulk drug manufacturer of Intermediates, Advanced Intermediates. Innovation has been forefront in our approach, powered by highly-qualified teams and use of cutting-edge technology. We are an USFDA approved (USFDA FEI No: 3014053359) company and are continuously expanding our product portfolio and our business to international markets.
Lofty Laboratories was founded in 2005 with a focus of creating impact in pharmaceutics value chain. Today we are a leading pharmaceutical bulk drug manufacturer of Intermediates, Advanced Intermediates. Innovation has been forefront in our approach, powered by highly-qualified teams and use of cutting-edge technology. We are an USFDA approved (USFDA FEI No: 3014053359) company and are continuously expanding our product portfolio and our business to international markets.
Recommended supplier
-
VIP4年
- GLP Pharma Standards
- 429658-95-7 Dabigatran Etexilate Mesilate - Impurity B/Dabigatran Etexilate Related Compound B NLT 95%
- Inquiry
- 2026-04-03
- Since:2020-01-01
- Address: HIG 148, KPHB COLONY, HYDERABAD, Telangana, 500072
INQUIRY